interscapular region subcutaneously with 10 4.7 LD~0 of virus in 0.05 ml. Control mice were injected with an extract of normal brain.
Determination of Virus and Interferon Levels in Plasma and
Liver. There were on the average eight suckling mice per litter. In the days after viral inoculation, litters were sacrificed; the plasma from mice in each litter were pooled and titered for virus or interferon as previously described (2) .
Virus in the liver (50% wt/vol homogenate) was titered by plaque assay in cultures of L cell monolayers (5) . In our experiments 1 plaque-forming unit is approximately the equivalent of 25 mouse LDs0.
Preparations and Assay of Mouse Interferon. Mouse C-243 cell interferon was prepared, concentrated, and partially purified as previously described (6) . Interferon was assayed as previously described (7) on monolayers of mouse L cells challenged with 100 median tissue culture infective doses (TCIDs0) of vesicular stomatitis virus. All plasma and liver homogenates were kept at pH 4 for 24 h to inactivate LCM virus before assay. Mouse interferon units quoted are as measured in our laboratory and one of our units equal four mouse interferon reference units.
Histology. Tissues were fixed in Bouin's solution and stained with hematoxylin and eosin.
Results

Disease in BALB/c, Swiss, and C3H Suckling Mice Inoculated at Birth with LCM Virus
GROWTH CURVE. To determine the effect of LCM virus on the growth of suckling mice, litters of BALB/c, Swiss, or C3H mice were left uninoculated, inoculated with normal brain extract, or inoculated with 10 4.7 LDs0 of LCM virus. All LCM virusinfected mice grew normally for the 1st wk of life ( Fig. 1 ). Thereafter, a slight inhibition of growth was observed for virus-infected BALB/c mice, a greater inhibition for Swiss mice, whereas virus-infected C3H mice lost weight ( Fig. 1 ).
MORTALITY. The results of several experiments presented in Fig. 2 show that 0/ 115 (0%) BALB/c mice, 47/129 (36%) Swiss mice, and 87/87 (100%) C3H mice, died in the 1st mo of life after inoculation of 10 't"7 LDs0 of LCM virus. C3H mice died sooner than Swiss mice ( Fig. 2 ). HISTOLOGIC EXAMINATION OF THE LIVER. In accord with our previous observations (2), the only gross and histologic abnormalities in virus-infected suckling mice were noted in the liver. In two experiments LCM virus-infected BALB/c, Swiss, and C3H mice were sacrificed and histologic sections of the liver were examined at different intervals or at a given time (9th d) ( 
TITERS OF VIRUS AND INTERFERON IN PLASMA AND LIVER. The results of the preceding
experiments showed that L C M virus disease was mild in BALB/c mice, of intermediate severity in Swiss mice, a n d most marked in C3H mice (as j u d g e d by effects on growth, incidence, a n d severity of liver lesions and percentage mortality). As shown in Fig. 4 (upper panel) and Fig. 5 this different pattern of disease was not attributable to differences in L C M virus multiplication because plasma and liver virus titers were similar in all three strains of mice, (as high in BALB/c mice as in C 3 H mice). A striking difference however was observed in the a m o u n t and duration of endogenous blood interferon induced in these strains of mice (lower panel, Fig. 4 ). BALB/c mice had a very low interferon response limited for the most part to the 3rd d; Swiss mice had greater a m o u n t s of interferon on the 3rd a n d 4th d. In contrast, C3H mice had high levels of plasma interferon on the 3rd to the 6th d. Liver interferon titers were uniformly low and inconsistent (due to cell toxicity of liver previously been shown to decrease the incidence of mortality in virus-infected Swiss mice (2) we undertook the same type of experiment in virus-infected C3H mice.
Newborn C3H mice inoculated with 105 LD~0 of LCM virus were injected on day 0 and day 3 with potent sheep anti-mouse interferon globulin (titer 8 × 10 -5) (8) . Whereas 100% of virus-infected control C3H mice died, (9th to 12th d), only 6/28 (21%) of anti-mouse interferon globulin-treated mice died. These six mice died between the 15th and the 27th d.
Exogenous Interferon Can Induce Disease in BALB/c Mice.
Although the minimal disease observed in LCM virus-infected BALB/c mice appeared to be related to their minimal interferon response, it was of interest to determine the sensitivity of BALB/c mice to daily administration of interferon. Accordingly, in five litters 11 newborn BALB/c mice were injected daily for 7 d with 0.05 ml of a mouse C-243 cell interferon preparation (6) having a titer of 1.6 × 10 -6. Eight litter mates were inoculated with a control preparation.
Interferon treatment inhibited the growth of suckling BALB/c mice. Thus, the mean weights (in grams) on the 8th d of life for interferon-treated suckling mice compared with control inoculated litter mates for the five litters were: interferon treated/control: 4/6. 
Discussion
The severity of disease observed in suckling mice injected at birth with LCM virus depends on the mouse strain (4) . In our studies BALB/c mice were relatively unaffected: they grew almost as well as uninfected mice, they had only minimal liver lesions and none died. In contrast, virus-infected C3H mice grew poorly, they had extensive liver cell degeneration, and all mice died. An intermediate pattern was observed in Swiss mice. In referring to the variation in mortality of LCM virusinfected suckling mice of different strains Von Boehmer and co-workers stated "we know of no cause which satisfactorily explains the differences between mouse strains or the fluctuation within strains" (4) . In agreement with the findings of Von Boehmer et al. (4) we found no difference in virus titers in plasma or liver between the three strains of mice ( Figs. 4 and 5) .
However, despite similar titers of virus in the plasma and liver, clear-cut differences in the amount of endogenous interferon produced and the duration of interferonemia was observed for the three strains of mice. Thus BALB/c mice produced small amounts of interferon detectable in the plasma mostly on the 3rd d; Swiss mice produced more interferon detectable on the 3rd and 4th d, whereas C3H mice produced larger amounts of interferon and interferonemia lasted between the 3rd and 6th d (Fig. 4) . Our results suggest therefore that the amplitude of the interferon response in C3H mice is in large part responsible for the severity of LCM disease. This interpretation is further supported by experiments showing a marked decrease in the incidence of mortality in virus-infected C3H mice when they were injected with a potent anti-mouse interferon globulin (Results). Furthermore, the relative resistance of BALB/c mice was not caused by insensitivity to interferon action because exogenous interferon did inhibit their growth and did induce comparable liver lesions. We suggest therefore that the minimal disease occurring in BALB/c mice was related to their minimal interferon response.
These experiments also suggest that there is a genetic control for the production of interferon in suckling mice infected with LCM virus. De Maeyer and his associates have described four loci which determine the interferon response in mice after injection of Newcastle disease (9) , mouse mammary (10), and Sendai (11) viruses. Work is in progress to determine whether the gene(s) controlling the production of interferon after infection with LCM virus is related to these previously described loci.
There is no question that interferon plays a beneficial role in most viral infections, and when administered, can confer considerable protection against viral infection. Our work emphasizes however, that potent biologic substances such as interferon can also be associated with untoward effects. Thus, in the study presented herein, it is the host response in C3H mice manifested as production of large amounts of interferon that proves injurious (100% mortality), whereas the minimal interferon response of BALB/c mice is associated with 100% survival. In LCM virus disease of adult mice, it is also the host response in the form of sensitized lymphocytes that appears to be responsible for disease (12) (13) (14) . Thus, in both suckling and adult mice, LCM viral multiplication itself is apparently well tolerated (15) , but it is the host response that is not tolerated. Recently, Hooks et al. (16) have found elevated levels of interferon in the sera of patients with severe systemic lupus erythematosis, and suggested the possibility that this interferon may play a pathogenetic role. Ida and co-workers (17) have suggested that the interferon produced in the course of respiratory infections may be responsible for some of the "allergic" manifestations. If we may extrapolate the results of our study and the extensive studies of De Maeyer et al. (9) (10) (11) , it seems possible that there is a genetic control for the production of interferon to different viruses in man. Individuals may vary in the extent of their interferon response to a given viral infection and in their sensitivity to the effects of interferon. In most instances this interferon response will prove beneficial, but possibly there are some instances where too much interferon will prove injurious in a given individual.
Summary
A marked difference was observed in the severity of disease in lymphocytic choriomeningitis (LCM) virus-infected suckling BALB/c, Swiss, and C3H mice. BALB/c mice had minimal liver lesions and none died, whereas C3H mice had extensive liver lesions and all mice died. An intermediate pattern was observed for Swiss mice (36% mortality). Although there was no difference in the titers of LCM virus in the plasma or liver between these three strains of mice, there was a marked difference in the amount of interferon produced and the duration of interferonemia. C3H mice produced more interferon than Swiss mice which produced more interferon than BALB/c mice~ indicating a direct correlation between the amount of interferon induced by LCM virus and the extent of disease. Inoculation of a potent anti-mouse interferon globulin markedly reduced the incidence of mortality in virus-infected C3H mice. BALB/c mice were as sensitive to the effects of interferon as C3H mice because daily administration of potent interferon preparations did induce disease in this strain. This ensemble of results supports our contention that endogenous interferon is in large part responsible for the manifestations of acute LCM virus disease in suckling mice.
